Stilla Technologies

France
Villejuif, Île-de-France, France, 94800

Company profile

Stilla Technologies company profile

Stilla Technologies is a Paris-based European Biotechnology company that focuses on accelerating the development of next-generation genetic tests by providing a ground-breaking and flexible digital PCR (dPCR) solution: the Naica System. Taking advantage of cutting-edge microfluidic innovations, Stilla aims to make dPCR a lab commodity to all Life Sciences areas: research, therapeutics, and all the “omics”.

Business identity

Contact email
[email protected]
Operating status
Active
Company type
For Profit
Employee range
51-100 employees
Revenue range
$1M-$10M
Founded
2013-01-01, Year

Headquarters

Postal code
94800
Country code
FR
Continent
Europe

Capital profile

Funding and company signals

Funding stage
M And A
Funding rounds
6
Total equity funding
$66.8M
Last funding
Series C / $26.5M / 2024-02-22
Last equity funding
Series C / $26.5M
Investors
14
Lead investors
6
Founders
4
Articles
35
Exited on
2025-02-13

Founders and investors

Founders

Charles BaroudClement GayEtienne FradetRemi Dangla

Lead investors

Casdin CapitalCLIFFEuropean Investment BankIllumina VenturesKurma PartnersTusholdings

Investors

Casdin CapitalEuropean Investment BankIdinvest PartnersIllumina VenturesKurma Partners